Amplify Seymour Cannabis ETF : CNBS

CNBS

Stock Data

$27.46

$0.95 (3.58%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

All CNBS Articles

5 Articles

John Seetoo | Jun 13, 2026 at 10:00 AM EDT

Dividend Safety Check: CNBS and Income in the Cannabis Sector

The Amplify Seymour Cannabis ETF (NYSEARCA:CNBS) sits at the awkward intersection of a thematic sector bet and an income wrapper.…

John Seetoo | Jun 9, 2026 at 1:10 PM EDT

CNBS Rallied Triple Digits On One Regulatory Bet, Not Dividends

The Amplify Seymour Cannabis ETF (NYSEARCA:CNBS) has rallied sharply in 2026, with shares up 105% over the past year and…

David Beren | May 6, 2026 at 9:24 AM EDT

Cannabis Rescheduling Could Unlock the Biggest MSO Rally Since 2021

Federal cannabis policy moved from theory to action this spring, and three ETFs sit closest to the trade. The AdvisorShares…

David Beren | Apr 23, 2026 at 12:21 PM EDT

The Last Cannabis ETFs Worth Your Money: Why Most Failed and 3 Are Still Trading

Cannabis ETFs entered 2026 after multiple fund closures, stalled federal reform, and a prolonged multi‑year drawdown in underlying equities. The…

Michael Williams | Jan 2, 2026 at 11:28 AM EST

After A Surprise Win In 2025, What Will 2026 Bring For The Amplify Cannabis ETF? | CNBS

Amplify Seymour Cannabis ETF (NYSEARCA:CNBS) posted a 17% gain in 2025, but that masks the real story. The fund surged…

Amplify Seymour Cannabis ETF : CNBS

CNBS

$27.46

All CNBS Articles

Dividend Safety Check: CNBS and Income in the Cannabis Sector

CNBS Rallied Triple Digits On One Regulatory Bet, Not Dividends

Cannabis Rescheduling Could Unlock the Biggest MSO Rally Since 2021

The Last Cannabis ETFs Worth Your Money: Why Most Failed and 3 Are Still Trading

After A Surprise Win In 2025, What Will 2026 Bring For The Amplify Cannabis ETF? | CNBS

The Case for Holding AVUV in Your Roth IRA

The Real Risk in Retirement Isn’t Running Out of Money. It’s Losing Your Purchasing Power.

He Thought Social Security Would Be Enough. A Knee Surgery and the Rising Cost of Living Sent Him Back to Work at 72.

The Real Risk in Retirement Isn't Running Out of Money. It's Losing Your Purchasing Power.

He Thought Social Security Would Be Enough. A Knee Surgery and the Rising Cost of Living Sent Him Back to Work at 72.

The Case for Holding AVUV in Your Roth IRA

The Real Risk in Retirement Isn’t Running Out of Money. It’s Losing Your Purchasing Power.

Amplify Seymour Cannabis ETF : CNBS

CNBS

$27.46

All CNBS Articles

Dividend Safety Check: CNBS and Income in the Cannabis Sector

CNBS Rallied Triple Digits On One Regulatory Bet, Not Dividends

Cannabis Rescheduling Could Unlock the Biggest MSO Rally Since 2021

The Last Cannabis ETFs Worth Your Money: Why Most Failed and 3 Are Still Trading

After A Surprise Win In 2025, What Will 2026 Bring For The Amplify Cannabis ETF? | CNBS

The Case for Holding AVUV in Your Roth IRA

The Real Risk in Retirement Isn’t Running Out of Money. It’s Losing Your Purchasing Power.

He Thought Social Security Would Be Enough. A Knee Surgery and the Rising Cost of Living Sent Him Back to Work at 72.

Featured Reads

The Real Risk in Retirement Isn't Running Out of Money. It's Losing Your Purchasing Power.

He Thought Social Security Would Be Enough. A Knee Surgery and the Rising Cost of Living Sent Him Back to Work at 72.